1. Introduction
liver injury, TG, headaches, Dyslipidemia
DYSLIPIDEMIA, DYSLIPIDEMIA
In the present study, we aimed to explore the feasibility, compliance, and potential benefits of Dyslipidemia is characterized by a decrease in plasma high-density lipoprotein cholesterol (HDL) or an increase in one or a combination of plasma triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL) levels [While medications are commonly used to reduce the risk of dyslipidemia, they often have side effects such as liver injury, flushing, headaches, and elevated LDL levels [In this context, However, to the best of our knowledge, no clinical studies have been conducted using NRE. Therefore, in this pilot study, we aimed to assess the feasibility, acceptability, and preliminary effects of NRE intervention on lipid profiles in both healthy and overweight/obese adults. 